Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study
•This subanalysis of the SoliRam study was conducted in people with type 2 diabetes mellitus receiving iGlarLixi during Ramadan in Gulf countries.•iGlarLixi was associated with low risk of hypoglycemia, including during Ramadan fasting.•Improvements were observed in HbA1c, FPG and body weight from p...
Gespeichert in:
Veröffentlicht in: | Diabetes research and clinical practice 2024-03, Vol.209, p.111567-111567, Article 111567 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!